Highlights

• 

  • 18 OCT 2019
  • HBS Blavatnik Fellowship in Life Sciences Entrepreneurship

  Blavatnik Fellowship Celebrates Five Years

  The Blavatnik Fellowship in Life Science Entrepreneurship offers HBS alumni the opportunity to create new ventures around promising life-science technologies while developing their leadership talents. Since 2013, 25 Fellows have completed the program, started 21 companies, and collectively raised $250M in funding. To learn more about the Fellowship and how the Blavatnik community is shaping the future of life science entrepreneurship
• 

  • 26 Aug 2019
  • Harvard University

  NEW MS/MBA Biotechnology: Life Sciences Joint Degree Program

  Learn more about the new joint degree MS/MBA Biotechnology: Life Sciences joint degree with the Harvard Graduate School of Arts and Sciences, Harvard Business School and the Harvard Department of Stem Cell and Regenerative Biology. Jill Fadule, Director of Joint Degree Programs, and Cara Sterling, Director of the HBS Health Care Initiatve discuss the benefits of this program in the podcast.
• 

  • 22 Aug 2019
  • Harvard Health Innovation Network

  Harvard Health Innovation Network - Upcoming Events

  The Harvard Health Innovation Network highlights the wide range of innovation & entrepreneurial events and opportunities offered by Harvard & affiliated hospitals. This network is open to all Harvard affiliates - students, practitioners, researchers & faculty - who want to explore a career in innovation and entrepreneurship, learn about how to evaluate and validate venture ideas, connect with a diverse community with a breadth of skill sets and apply for startup funding competitions.
• 

  • 24 Aug 2019
  • HBS Kraft Precision Medicine Accelerator

  HBS Kraft Precision Medicine Accelerator

  This is a time of amazing scientific discoveries and breakthroughs. Traditional funding models are not sufficient for the current opportunity, and while interest in impact investing is high, health care impact investing lags behind. Innovative new funding models for drug development show tremendous promise, and there are opportunities to build on and accelerate successful emerging funding models. Learn more about how we are driving that progress at the Kraft Precision Medicine Accelerator.